NDA 214252 describes REGADENOSON, which is a drug marketed by
Accord Hlthcare,
Apotex,
Baxter Hlthcare Corp,
Dr Reddys,
Eugia Pharma,
Gland Pharma Ltd,
Hikma,
Hospira,
Ims Ltd,
Meitheal, and
Mylan, and is included in eleven NDAs. It is available from
twelve suppliers. Additional details are available on the
REGADENOSON profile page.
The generic ingredient in REGADENOSON is
regadenoson. There are nine
drug master file entries for this compound. Fourteen
suppliers are listed for this compound. Additional details are available on the
regadenoson profile page.